| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1343d37ea00c42befe12e7abf3467ec5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17f3bbaa0f8408871485ec217e821d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26497515d05fc8216b91c276bcafd785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c917f27c00403bad0767c053d15f3bd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
| filingDate |
2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5ed8966ee9ffc9c943119b1b76873a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c4b3d663f814d3b8240c0725722288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_393e80b03d6a24834e81b00dc30c9894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd21574dd47f7b0da588288a02e66aeb |
| publicationDate |
2004-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004058170-A2 |
| titleOfInvention |
Methods for treating malaria by modulation of g protein function |
| abstract |
The present invention is directed to methods and pharmaceutical compositions for treating a mammal suffering from malaria or the sequelae of malarial infection, or for preventing a malarial infection, or for ameliorating the symptoms associated with a malarial infection using a therapeutically effective amount of an agent that down regulates G protein mediated functions. Also contemplated are methods for screening for novel compounds that down regulate G protein receptors, and the use of these compounds for treating mammals having malaria. |
| priorityDate |
2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |